AddLife AB (LTS:0REZ) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0REZ AddLife AB LTS:0REZ
82 GF Score
Price kr163.78
GF Value kr154.17
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is AddLife AB Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AddLife AB  (LTS:0REZ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AddLife AB Cyclically Adjusted PS Ratio Related Terms


AddLife AB Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for AddLife AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB Cyclically Adjusted PS Ratio Chart

AddLife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.67

AddLife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.61 3.39 2.63 2.25 2.57

LTS:0REZ vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted PS Ratio falls into.


LTS:0REZ
82GF Score
AddLife AB LTS:0REZ
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AddLife AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, AddLife AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=22.328/134.6100*134.6100
=22.328

Current CPI (Jun. 2026) = 134.6100.

AddLife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.959 101.138 5.269
201612 5.967 102.022 7.873
201703 5.620 102.022 7.415
201706 5.581 102.752 7.311
201709 5.054 103.279 6.587
201712 6.569 103.793 8.519
201803 5.877 103.962 7.610
201806 6.123 104.875 7.859
201809 5.722 105.679 7.288
201812 6.765 105.912 8.598
201903 8.109 105.886 10.309
201906 7.477 106.742 9.429
201909 7.095 107.214 8.908
201912 8.803 107.766 10.996
202003 9.311 106.563 11.762
202006 11.117 107.498 13.921
202009 11.058 107.635 13.829
202012 15.409 108.296 19.153
202103 15.408 108.360 19.141
202106 18.774 108.928 23.200
202109 15.171 110.338 18.508
202112 17.474 112.486 20.911
202203 21.091 114.825 24.725
202206 17.082 118.384 19.423
202209 17.150 122.296 18.877
202212 19.095 126.365 20.341
202303 20.125 127.042 21.324
202306 19.408 129.407 20.188
202309 19.030 130.224 19.671
202312 20.877 131.912 21.304
202403 21.090 132.205 21.474
202406 20.958 132.716 21.257
202409 19.235 132.304 19.570
202412 23.124 132.987 23.406
202503 22.172 132.825 22.470
202506 21.155 133.699 21.299
202509 19.932 133.480 20.101
202512 22.427 133.380 22.634
202603 21.705 133.550 21.877
202606 22.328 134.610 22.328

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is AddLife AB (LTS:0REZ) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of kr163.78 is trading 6.2% above its estimated GF Value™ of kr154.17. GuruFocus considers AddLife AB to be Fairly Valued.

Key valuation signals for LTS:0REZ:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: kr154.17 vs. price of kr163.78 (6.2% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the LTS:0REZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
82GF Score

Get the complete analysis for LTS:0REZ

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr163.78
Price
kr154.17
GF Value